Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. ADC Therapeutics SA (ADCT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.ADC Therapeutics SA is one of 947 individual stocks in the Medical sector. Collectively, these companies sit at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. ADC Therapeutics SA is currently sporting a Zacks Rank of #2 (Buy).Within the past quarter, the Zacks Consensus Estimate for ADCT's full-year earnings has moved 15% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.Our latest available data shows that ADCT has returned about 99.5% since the start of the calendar year. At the same time, Medical stocks have gained an average of 6.2%. This means that ADC Therapeutics SA is performing better than its sector in terms of year-to-date returns.Catalyst Pharmaceutical (CPRX) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 15.9%.For Catalyst Pharmaceutical, the consensus EPS estimate for the current year has increased 8.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).Looking more specifically, ADC Therapeutics SA belongs to the Medical - Biomedical and Genetics industry, a group that includes 465 individual stocks and currently sits at #89 in the Zacks Industry Rank. This group has gained an average of 18.4% so far this year, so ADCT is performing better in this area. On the other hand, Catalyst Pharmaceutical belongs to the Medical - Drugs industry. This 146-stock industry is currently ranked #78. The industry has moved +6% year to date.Investors with an interest in Medical stocks should continue to track ADC Therapeutics SA and Catalyst Pharmaceutical. These stocks will be looking to continue their solid performance.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ADC Therapeutics SA (ADCT): Free Stock Analysis Report Catalyst Pharmaceuticals, Inc. (CPRX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks